Literature DB >> 34458476

Knock-in Blunt Ligation Utilizing CRISPR/Cas9.

Jonathan M Geisinger1, Michele P Calos2.   

Abstract

The incorporation of the CRISPR/Cas9 bacterial immune system into the genetic engineering toolbox has led to the development of several new methods for genome manipulation ( Auer et al., 2014 ; Byrne et al., 2015 ). We took advantage of the ability of Cas9 to generate blunt-ended double-strand breaks ( Jinek et al., 2012 ) to introduce exogenous DNA in a highly precise manner through the exploitation of non-homologous end-joining DNA repair machinery ( Geisinger et al., 2016 ). This protocol has been successfully applied to traditional immortalized cell lines and human induced pluripotent stem cells. Here we present a generalized protocol for knock-in blunt ligation, using HEK293 cells as an example.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  CRISPR/Cas9; Cell culture; Double-strand breaks; Genome engineering; NHEJ

Year:  2017        PMID: 34458476      PMCID: PMC8376541          DOI: 10.21769/BioProtoc.2163

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  5 in total

1.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

2.  Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining.

Authors:  Marcello Maresca; Victor Guosheng Lin; Ning Guo; Yi Yang
Journal:  Genome Res       Date:  2012-11-14       Impact factor: 9.043

3.  Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair.

Authors:  Thomas O Auer; Karine Duroure; Anne De Cian; Jean-Paul Concordet; Filippo Del Bene
Journal:  Genome Res       Date:  2013-10-31       Impact factor: 9.043

4.  Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells.

Authors:  Susan M Byrne; Luis Ortiz; Prashant Mali; John Aach; George M Church
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

5.  In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining.

Authors:  Jonathan M Geisinger; Sören Turan; Sophia Hernandez; Laura P Spector; Michele P Calos
Journal:  Nucleic Acids Res       Date:  2016-01-13       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.